Research Article

Genetic Toxicology and Safety Pharmacological Evaluation of Forsythin

Table 2

Results of the chromosomal aberrations test for forsythin.

GroupDosage (µg/ml)Number of cells scoredNo. of cells with aberrations
−S9+S9
24 h48 h6–18 h

DMSOa2004.02.52.0
Mitomycin Cb0.2520014.518.5
Cyclophosphamideb2020019.0
Forsythin1252005.02.55.0
2502004.51.55.0
5002005.05.04.5

aNegative control. bPositive control. , compared with the negative control group. , compared with the negative control group.